β2 adrenergic agonists in acute lung injury? The heart of the matter

Critical Care

Volumn 13, Issue 6, 2009, Pages

  Lee, Jae W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; OLEIC ACID; SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; TERBUTALINE;

ACUTE LUNG INJURY; DISEASE SEVERITY; DOG; IN VIVO CULTURE; LUNG ENDOTHELIUM; NONHUMAN; NOTE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; DISEASE MODEL; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CIRCULATION; RANDOMIZED CONTROLLED TRIAL;

ACUTE LUNG INJURY; ADRENERGIC BETA-AGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HUMANS; INFUSIONS, INTRAVENOUS; PULMONARY CIRCULATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; TERBUTALINE;

EID: 77951642424     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8171     Document Type: Note

References (13)

1. Briot R, Bayat S, Anglade D, Martiel JL, Grimbert F. Increased cardiac index due to terbutaline treatment aggravates capillary-alveolar macromolecular leakage in oleic acid lung injury in dogs. Crit Care 2009, 13:R166. 10.1186/cc8137, 2784397, 19845949.
2. Briot R, Bayat S, Anglade D, Martiel JL, Grimbert F. Monitoring the capillary-alveolar leakage in an A.R.D.S. model using broncho-alveolar lavage. Microcirculation 2008, 15:237-249. 10.1080/10739680701647410, 18386219.
3. Schäfers RF, Adler S, Daul A, Zeitler G, Vogelsang M, Zerkowski HR, Brodde OE. Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment. J Am Coll Cardiol 1994, 23:1224-1233.
4. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002, 82:569-600.
5. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, Hutter D, Turini P, Hugli O, Cook S, Nicod P, Scherrer U. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002, 346:1631-1636. 10.1056/NEJMoa013183, 12023995.
6. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163:1376-1383.
7. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004, 32:1470-1476. 10.1097/01.CCM.0000129489.34416.0E, 15241090.
8. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, Zee JS, Bresser P, Poll T. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005, 172:878-884. 10.1164/rccm.200503-451OC, 15994467.
9. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173:281-287. 10.1164/rccm.200508-1302OC, 16254268.
10. Matthay M, Brower R, Thompson BT, Schoenfeld D, Eisner MD, Carson S, Moss M, Douglas I, Hite D, MacIntyre N, Liu KD. Randomized, placebo-controlled trial of an aerosolized beta-2 adrenergic agonist (albuterol) for the treatment of acute lung injury. Am J Respir Crit Care Med 2009, 179:A2166.
11. Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991, 88:864-875. 10.1172/JCI115388, 295473, 1885774.
12. Perkins GD, Gao F, Thickett DR. In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. Thorax 2008, 63:215-220. 10.1136/thx.2007.080382, 17951278.
13. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008, 178:618-623. 10.1164/rccm.200803-419OC, 2542435, 18565951.